Fluorescence Innovations

Name

Fluorescence Innovations

Legal name

Fluorescence Innovations, Inc.

Website

https://fluorescenceinnovations.com

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Scientific Instrumentation — Fluorescence Lifetime Plate Readers

NAICS

Analytical Laboratory Instrument Manufacturing (334516), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)

SIC

Laboratory Analytical Instruments (3826)

akta.pro primary industry

Analytical Instruments & Chromatography Systems (HLAGAIAA)

akta.pro secondary industries

Mass Spectrometry & Spectroscopy Instruments (HLAGAIAB), Stability Testing (ICH Programs) (HLAGADAD), Biomarker Discovery & Validation (omics, assay feasibility, clinical validation) (HLAAAMAA)

Keywords

• Fluorescence lifetime measurement
• Microplate reader instruments
• High throughput screening
• Protein stability analysis
• Drug discovery instrumentation

Headquarters

HQ city

Minneapolis

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales

Revenue model

1. NovaFluor PR Plate Reader Sales: Sale of specialized fluorescence lifetime microplate readers for drug discovery and research applications
2. NovaFluor PRO Protein Stability Plate Reader: Sale of protein stability determination instrumentation for temperature and chemical environment analysis
3. Pharma Licensing Agreement: Multi-year major pharma license agreement with Photonic Pharma (December 2015) for the technology
4. Assay Development Services: Custom assay development services for specific customer needs as welcomed on their website

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Core offering

Fluorescence Innovations designs, builds, and markets scientific instrumentation that measures the fluorescence lifetime properties of biological systems. Its flagship offering is the NovaFluor PR Fluorescence Lifetime Plate Reader — the first instrument using its proprietary Direct Waveform Recording™ technology — and it also sells the NovaFluor PRO Protein Stability Plate Reader for determining protein stability as a function of temperature and chemical environment. The instruments target drug discovery, ligand binding, protein conformation, and live cell assays in 96-, 384-, and 1536-well plate formats.

Product overview

Fluorescence Innovations offers a portfolio of fluorescence lifetime measurement instruments built around its proprietary Direct Waveform Recording™ technology. The core product is the NovaFluor PR Fluorescence Lifetime Plate Reader, which was the first instrument to utilize Direct Waveform Recording™. The company also offers the NovaFluor PRO Protein Stability Plate Reader for determining protein stability as a function of temperature and chemical environment. Both instruments are designed for high-throughput screening applications including protein conformation studies, ligand binding assays, and live cell assays.

Differentiator

Problem solved

Functional benefit

Brands

• NovaFluor PR: Fluorescence Lifetime Plate Reader using Direct Waveform Recording technology for high throughput screening applications including protein conformation, ligand binding, and live cell assays.
• NovaFluor PRO
• Direct Waveform Recording

Products and services

• NovaFluor PR Fluorescence Lifetime Plate Reader The first fluorescence lifetime microplate reader built on Direct Waveform Recording™ technology, capable of measuring 96-, 384-, and 1536-well plates at up to ten wells per second with continuous scanning across the central 50% of each well or stop-and-go mode. It is sold to pharmaceutical, biotechnology, and academic research groups for protein conformation, ligand binding, and live cell FRET-based assays, with 1536-well plate reads in under 2 minutes and SNR exceeding 500:1.
• NovaFluor PRO Protein Stability Plate Reader Specialized microplate reader designed to rapidly determine protein stability as a function of temperature and chemical environment. Available with a protein aggregation option, it uses small amounts of protein per well with low cost per sample. Targeted at academic structural biology and protein characterization groups, including NIH Protein Structure Initiative work on membrane protein crystallization.
• Custom Assay Development Services Custom assay development services offered by Fluorescence Innovations, welcoming direct inquiries from customers needing specific fluorescence lifetime assay development on the Direct Waveform Recording™ platform for life sciences research applications.

Quantifiable outcome

• 1536-well plate read time under 2 minutes
• +5 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Five partnerships are on record, tiered core and minor.

• Photonic PharmacoreStrategic or Co-development Partner · 22 December 2015Multi-year collaboration and major pharma license agreement effective December 22, 2015. Photonic Pharma licensed the technology for pharmaceutical applications.
• Montana MolecularcoreStrategic or Co-development PartnerTeamed up to develop new live cell assays for the NovaFluor PR Fluorescence Lifetime Microplate Reader. Combined Montana Molecular's genetically encoded sensors with Fluorescence Innovations' Direct Waveform Recording technology.
• Thomas Research Group, University of MinnesotacoreStrategic or Co-development PartnerCollaborative development of Direct Waveform Recording technology. The Thomas research group is a world leader in developing spectroscopic probes and led early development of DWR technology.
• University of Colorado, Department of Molecular BiologyminorStrategic or Co-development PartnerUniversity chose NovaFluor PR as platform to develop high-throughput stability assays for membrane protein crystallization as part of NIH Protein Structure Initiative.
• University of Minnesota - DuluthminorStrategic or Co-development PartnerCollaborative research project studying protein synaptotagmin C2A domain using Fluorescence Innovations' tunable UV source for fluorescence lifetime measurements across temperature ranges.

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

Market position

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/fluorescence-innovations-inc

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fluorescence Innovations